ArticleThe Journal of steroid biochemistry and molecular biology2017

Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2- and ER+HER2+) breast cancers.

Noriko Kanaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.